首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cancer treatment and research communications

缩写:

ISSN:2468-2942

e-ISSN:2468-2942

IF/分区:2.4/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引1000
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Jemima Steele,Emma Taylor,Sawsan Khuri et al. Jemima Steele et al.
Non-small cell lung cancer is a significant cause of cancer-related death worldwide. Current treatment modalities for advanced-stage non-small cell lung cancer can be intrusive, with limited efficacy and unfavourable side effect profiles. H...
Eisuke Mochizuki,Shun Matsuura,Naoki Koshimizu et al. Eisuke Mochizuki et al.
Background: Platinum-based chemotherapy combined with immune checkpoint inhibitor therapy has recently been introduced for treating extensive-stage small-cell lung cancer (ES-SCLC). In the Phase III CASPIAN study, first-l...
Mary C Clouser,Mina Suh,Naimisha Movva et al. Mary C Clouser et al.
Background: Methylthioadenosine phosphorylase (MTAP) deficiency is observed across multiple cancers and represents an emerging biomarker with therapeutic potential via synthetic lethality with PRMT5 inhibition. This syste...
Aboma Motuma,Ibsa Mussa,Alemayehu Deressa et al. Aboma Motuma et al.
Background: The incidence of breast cancer increased over the last few decades, however, it is less known about the relationship between central obesity and breast cancer incidence irrespective menopause. Given the increa...
Rolando J Acosta,Debra A G McIntyre,Joseph C Murray et al. Rolando J Acosta et al.
Background: Patients with a high neutrophil/lymphocyte ratio (NLR) have poor prognosis in non-small cell lung cancer (NSCLC). Limited data are available on the contribution of other immune cells. This analysis assessed th...
Natalia Fernández Núñez,Martín Lázaro Quintela,Jorge García González et al. Natalia Fernández Núñez et al.
Introduction: Patients with advanced non-small cell lung cancer (NSCLC) who progress after chemotherapy and immune checkpoint inhibitors (ICIs) need effective second-line treatments. The combination of nintedanib and doce...
K M Renu,Abhinay Kumar Singh,Masroor Anwar et al. K M Renu et al.
Background: Klotho, an antioxidant protein, suppresses oxidative stress and its potential role in cancer due to shared molecular hallmarks with aging. The expression of Klotho in breast cancer (BC) tissue and circulation ...
Meaghan Polack,Gabi W van Pelt,Augustinus S L P Crobach et al. Meaghan Polack et al.
Background: Colorectal cancer is highly prevalent. The stromal tumour microenvironment significantly influences tumour behaviour, and cancer-associated fibroblasts (CAFs), as major component of tumour stroma, are increasi...
Francesca Del Debbio,Maria Sofia Bertilacchi,Andrea Cavalieri et al. Francesca Del Debbio et al.
Lung cancer is the second leading cause of cancer-related deaths. Treatment based on conventional radiotherapy often results in severe side effects, such as pulmonary fibrosis, a fatal and untreatable condition. FLASH radiotherapy is an eme...
Divya Panyam Vuppu,Priya Bhati,Saumya Gupta et al. Divya Panyam Vuppu et al.
Background: Over 70 % of advanced ovarian cancer cases involve metastasis to the peritoneum, diaphragm, and liver. Standardised diaphragm surgeries are vital for achieving complete cytoreduction and enhancing patient prog...